Publications by authors named "Yu-long Fu"

Article Synopsis
  • CD8+ T cells play a crucial role in controlling HIV-1, and understanding their metabolism is important for developing therapies for those living with HIV-1.
  • High plasma glutamate levels are found in people living with HIV-1, correlating with larger HIV-1 reservoirs and decreased CD8+ T cell function.
  • The study indicates that targeting glutamate metabolism, particularly its effects on CD8+ T cell activity via the mTORC1 pathway, could offer new therapeutic strategies to enhance anti-HIV responses.
View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on boosting HBV-specific T cell immunity as a potential treatment for chronic Hepatitis B by developing assays to monitor T cell responses.
  • Different immunological phases in patients with chronic Hepatitis B were analyzed to understand T cell responses and the effects of metabolic interventions.
  • Results showed that T cell responses were more effective in certain disease phases, with specific interventions amping up the function of HBV env-specific T cells, potentially guiding new therapeutic strategies.
View Article and Find Full Text PDF
Article Synopsis
  • Recent research indicates that CD8+ T cells are crucial in controlling HIV-1 reservoirs in individuals on antiretroviral therapy, although their exact mechanisms are still unclear.
  • In a study of 60 virologically suppressed HIV-1 patients, certain CD8+ T cell subsets were found to correlate with levels of HIV-1 DNA and RNA, revealing that specific central and terminally differentiated memory cells behaved differently in their responses.
  • The findings suggest that CCL5-secreting CD8+ T cells may play a key role in limiting HIV-1 reservoirs, paving the way for new CD8+ T cell-based treatments aimed at curing HIV-1 infection.
View Article and Find Full Text PDF

Objective: A comprehensive immune landscape for HBV infection is pivotal to achieve HBV cure.

Design: We performed single-cell RNA sequencing of 2 43 000 cells from 46 paired liver and blood samples of 23 individuals, including six immune tolerant, 5 immune active (IA), 3 acute recovery (AR), 3 chronic resolved and 6 HBV-free healthy controls (HCs). Flow cytometry and histological assays were applied in a second HBV cohort for validation.

View Article and Find Full Text PDF

Background: Targeting immune checkpoints for HIV treatment potentially provides a double benefit resulting from the ability to restore viral-specific CD8 T-cell functions and enhance HIV production from reservoir cells. Despite promising pre-clinical data, PD-1 blockade alone in HIV-1-infected patients with advanced cancer has shown limited benefits in controlling HIV, suggesting the need for additional targets beyond PD-1. CD39 and PD-1 are highly co-expressed on CD8 T cells in HIV-1 infection.

View Article and Find Full Text PDF

CAR-T cell-based immunotherapy has shown great promise in clinical trials for the treatment of hematological malignancies. The majority of these trials utilize retroviral and lentiviral vectors to introduce CAR transgene. In spite of its satisfactory efficiency, the concerns about the potential carcinogenicity and complicated synthesis procedure restrict widespread clinical applications of viral vectors.

View Article and Find Full Text PDF

Adoptive immunotherapy using chimeric antigen receptors-modified T cells (CAR-T) is a promising approach for cancer treatment. However, CARs currently applied in the clinics cannot be effectively regulated and the safety of CAR-T cell therapies remains a major concern. To improve the safety of CAR-T cells, we designed a synthetic splitting CAR (ssCAR) that can regulate T cell functions exogenously.

View Article and Find Full Text PDF

The security of protocol implementation is important and hard to be verified. Since the penetration testing is usually based on the experience of the security tester and the specific protocol specifications, a formal and automatic verification method is always required. In this paper, we propose an extended model of IOLTS to describe the legal roles and intruders of security protocol implementations, and then combine them together to generate the suitable test cases to verify the security of protocol implementation.

View Article and Find Full Text PDF

Human augmenter of liver regeneration (hALR) is a sulfhydryl oxidase that is highly expressed in spermatogonia and early spermatocytes. To investigate the physiological effects of hALR in spermatogenesis, we generated a hALR transgenic mouse model driven by the human TSPY (testis-specific protein, Y-encoded) promoter that allows the transgene to be specifically activated in the testes. hALR content was found to be increased in both germ cells.

View Article and Find Full Text PDF

Aim: PKHDL1 (the gene for Polycystic Kidney and Hepatic Disease Like-1) had been recently identified, but characteristics of the gene product, Fibrocystin-L (FPC-L), still remain unknown. We therefore produced a rabbit polyclonal antibody hFL-Np to explore the cellular characteristics of this novel protein.

Methods: Based on the hydrophobic/hydrophilic analyses, chose a cDNA fragment which encodes 633L-768K amino acids of the FPC-L and amplified it by RT-PCR.

View Article and Find Full Text PDF

To gain new insight into the biological function of the human augmenter of liver regeneration (hALR) in HCC, we studied its involvement in radiation-induced damage and recovery of HCC cells. We found that hALR expression was up-regulated in both HCC tissues and multiple hepatoma cell lines and correlated significantly with increased radiation clonogenic survival after radiation treatment. Exogenous expression of hALR increased radiation resistance in SMMC-7721 cells, and the increased survival was accompanied by a decrease in apoptosis and a prolonged G(2)-M arrest after irradiation.

View Article and Find Full Text PDF